DCF Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

DCF Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$465K	–	92
2021 Q4	$465K	Hold	5,000	–	–	0.19%	58
2021 Q3	$298K	Hold	5,000	–	–	0.13%	71
2021 Q2	$341K	Hold	5,000	–	–	0.12%	79
2021 Q1	$347K	Sell	5,000 -1,000	-17%	-$77K	0.15%	86
2020 Q4	$461K	Sell	6,000 -10,000	-63%	-$750K	0.19%	71
2020 Q3	$1.2M	Hold	16,000	–	–	0.61%	35
2020 Q2	$1.01M	Sell	16,000 -500	-3%	-$27.5K	0.56%	39
2020 Q1	$693K	Buy	+16,500	New	+$757K	0.45%	41

DCF Advisers's ARNA Position: Q1 2022 in Review

DCF Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,000 shares — an estimated $465K sold.

DCF Advisers first reported a position in ARNA in Q1 2020 and held it in 8 quarters. The position peaked at $1.2M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

DCF Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
DCF Advisers sold 5,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $465K.
DCF Advisers first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 8 quarters.
DCF Advisers's Arena Pharmaceuticals Inc position peaked at $1.2M in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on DCF Advisers's 13F filing for Q1 2022, filed 13 May 2022.